Perspectives on This Article from Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668

NIAID Data Ecosystem2026-05-16 收录

数据链接：

https://figshare.com/articles/dataset/Perspectives_on_This_Article_from_Phase_0_Clinical_Chemoprevention_Trial_of_the_Akt_Inhibitor_SR13668/22524753 数据链接链接失效反馈

官方服务：

资源简介：

Perspectives on This Article from Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668

创建时间：

2011-03-01

Dataset from A Single-centre, Double-blind (Sponsor Open), Placebo Controlled Two Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 as a Dry Powder in Healthy Participants Who Smoke Cigarettes

吸入药物药代动力学

早期临床试验

This study is the first administration of GSK2292767 to humans. The study will evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and repeat inhaled doses of

NIAID Data Ecosystem40

Experimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials

神经保护药物研发

早期临床试验

Idiopathic intracranial hypertension is a neurological condition characterized by a raised intracranial pressure and papilledema that causes debilitating headaches. While the extent of the pathophysio

Figshare2023-11-25 更新30

A Randomized, Double-blind, Single Ascending Dose Study to Determine the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3772847 Administered Subcutaneously in Healthy Participants

早期临床试验

哮喘免疫治疗

GSK3772847, an anti-interleukin (IL) 33-receptor monoclonal antibody, is a novel treatment for asthma. The purpose of this study to evaluate the safety and tolerability, PK and PD of single ascendin

DataCite Commons2024-12-02 更新20

Dataset from An Open Label, Part-randomised, Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate (FF) When Administered as FF Inhalation Powder From the Novel Dry Powder Inhaler in Healthy Subjects

吸入药物药代动力学

早期临床试验

The purpose of this study is to demonstrate dose proportionality of the FF (50 microgram (mcg), 100 mcg or 200 mcg), when administered as a single and repeat dose from the NDPI containing FF formulate

NIAID Data Ecosystem30

Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R against liver cancer - Supplementary material

早期临床试验

癌症靶向治疗

Supplementary Table I Target lesion characteristic in each groupSupplementary Table II Summary of adverse events in each group

Figshare2024-04-04 更新20